In many clinical trials, particularly those evaluating cardiovascular outcomes, accurate and consistent assessment of clinical events is essential for reliable study results. A Clinical Endpoint Adjudication Committee (CEAC) – also referred to as an Adjudication Committee or Endpoint Adjudication Board – is an independent panel of clinical experts responsible for reviewing and classifying important clinical events that occur during a study.
The main purpose of a CEAC is to ensure that key study endpoints, such as arrhythmias, myocardial infarction, hospitalizations, or deaths, are evaluated objectively and according to predefined criteria. By independently reviewing clinical documentation submitted by study sites, including ECGs, imaging data, laboratory results, and medical records, the committee determines whether reported events meet the protocol-defined definitions for primary or secondary endpoints.
Independent endpoint adjudication helps ensure that events are assessed consistently across all participating study centers. This reduces variability in event reporting, minimizes potential bias, and strengthens the overall scientific validity of the study. As a result, CEACs play an important role in enhancing the credibility of trial outcomes and supporting regulatory submissions, where independent adjudication is often expected.
At SCIRENT, we support sponsors in establishing and managing Clinical Endpoint Adjudication Committees for clinical trials. Our services include the identification and engagement of experienced clinical experts, the development of adjudication charters and standardized processes, as well as the coordination and documentation of adjudication procedures. We ensure that all relevant clinical data is collected, prepared, and presented to the committee in a structured and compliant manner.
Through our expertise in clinical research and trial oversight, SCIRENT ensures that endpoint adjudication is conducted efficiently, transparently, and in accordance with regulatory and scientific standards, contributing to robust and reliable study results.
